A Study to Determine the Effects of MK0557 in Obese Subjects
Latest Information Update: 09 May 2022
At a glance
- Drugs MK 0557 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 12 May 2014 New trial record
Latest Information Update: 09 May 2022